KBGGY vs. NVO
Compare and contrast key facts about Kongsberg Gruppen ASA (KBGGY) and Novo Nordisk A/S (NVO).
Performance
KBGGY vs. NVO - Performance Comparison
Loading graphics...
KBGGY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
KBGGY Kongsberg Gruppen ASA | 75.04% | 19.00% | 164.60% | -2.54% |
NVO Novo Nordisk A/S | -25.80% | -39.22% | -15.93% | 21.90% |
Fundamentals
Returns By Period
In the year-to-date period, KBGGY achieves a 75.04% return, which is significantly higher than NVO's -25.80% return.
KBGGY
- 1D
- 1.83%
- 1M
- 6.80%
- YTD
- 75.04%
- 6M
- 42.08%
- 1Y
- 54.05%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NVO
- 1D
- -0.73%
- 1M
- -0.01%
- YTD
- -25.80%
- 6M
- -36.19%
- 1Y
- -43.88%
- 3Y*
- -20.88%
- 5Y*
- 3.69%
- 10Y*
- 5.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KBGGY vs. NVO — Risk / Return Rank
KBGGY
NVO
KBGGY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kongsberg Gruppen ASA (KBGGY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KBGGY | NVO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.66 | -0.81 | +1.48 |
Sortino ratioReturn per unit of downside risk | 1.44 | -0.99 | +2.43 |
Omega ratioGain probability vs. loss probability | 1.23 | 0.86 | +0.37 |
Calmar ratioReturn relative to maximum drawdown | 0.87 | -0.82 | +1.69 |
Martin ratioReturn relative to average drawdown | 1.18 | -1.41 | +2.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| KBGGY | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.66 | -0.81 | +1.48 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.10 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.16 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.29 | 0.46 | +0.83 |
Correlation
The correlation between KBGGY and NVO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
KBGGY vs. NVO - Dividend Comparison
KBGGY's dividend yield for the trailing twelve months is around 3.32%, less than NVO's 4.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KBGGY Kongsberg Gruppen ASA | 3.32% | 5.82% | 1.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.94% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Drawdowns
KBGGY vs. NVO - Drawdown Comparison
The maximum KBGGY drawdown since its inception was -68.35%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for KBGGY and NVO.
Loading graphics...
Drawdown Indicators
| KBGGY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.35% | -74.70% | +6.35% |
Max Drawdown (1Y)Largest decline over 1 year | -68.35% | -55.03% | -13.32% |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.70% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -37.27% | -73.49% | +36.22% |
Average DrawdownAverage peak-to-trough decline | -18.68% | -17.56% | -1.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.45% | 31.83% | +18.62% |
Volatility
KBGGY vs. NVO - Volatility Comparison
Kongsberg Gruppen ASA (KBGGY) has a higher volatility of 14.32% compared to Novo Nordisk A/S (NVO) at 9.39%. This indicates that KBGGY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| KBGGY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.32% | 9.39% | +4.93% |
Volatility (6M)Calculated over the trailing 6-month period | 39.46% | 38.79% | +0.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 82.01% | 54.16% | +27.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.34% | 37.82% | +24.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.34% | 32.28% | +30.06% |
Financials
KBGGY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Kongsberg Gruppen ASA and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities